PRE 14C

PRELIMINARY INFORMATION STATEMENT

Company: CITIUS ONCOLOGY, INC.
Filed: January 20, 2026
Period of Report: January 20, 2026
Accession Number: 0001213900-26-005689

View Document ↗ View on SEC.gov ↗